Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
07 November 2024
| Name: | MEDIVAC LIMITED (MDV) | ||||||
| Date of Listing: | 12 November 1993 | ||||||
| Date of Delisting: | 03 October 2016 | ||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 03 October 2016.Legal Status:
ACN: 055 747 941
To our knowledge this is a current registered entity, not in any form of external administration. Subsequent to delisting it may have changed its name. If you have questions about your shareholding they may be taken up with us here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.Capital Gains Tax (CGT) Status:
The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| MEDIVAC LIMITED | 22/01/2004 | |
| NAUTILUS AUSTRALIA LIMITED | 22/01/2004 |
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
the company, now GROWTH CAPITAL GROUP LIMITED, emerges from administration | 17/02/2021 |
company has been renamed GROWTH CAPITAL GROUP LIMITED and is still in external administration | 24/11/2020 |
the Deed Administrators are currently liaising with a Director of the company in relation to a potential variation of the Deed of Company Arrangement and convening of a shareholders meeting | 22/07/2019 |
delisted from the close of trading on Monday, 3 October 2016 pursuant to Listing rule 17.12. | 03/10/2016 |
we understand the company failed and was delisted following ASX's refusal of an extension to the 1 October 2016 relisting deadline | 03/10/2016 |
The Company has terminated the Term Sheet entered into with Brand TV Media Pty Ltd ("BTV") announced on 29 August 2016. The ASX has refused the Company an extension from the 1 October 2016 relisting deadline and as such the Company acknowledges that it is unable to satisfy the Indicative Timetable announced and relevant Conditions Precedent within the Term Sheet. The Company and BTV have executed a letter of settlement, terminating the Term Sheet which releases one another from all liabilities thereunder. The board of MDV is disappointed with this outcome. | 26/09/2016 |
Medivac Limited announces that the Company has on 26 August 2016 entered into a binding term sheet with the shareholders of Brand TV Media Pty Ltd in relation to the proposed acquisition of the entire equity interest in Brand TV Media Pty Ltd by the Company. The Proposed Acquisition will result in a Reverse Takeover of the Company as defined in Chapter 1 and 2 of the Listing Rules of ASX and is subject to, inter alia, the approval of the ASX and the approval of the shareholders of the Company at a general meeting of shareholders to be convened. | 29/08/2016 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation. | 23/08/2016 |
The company issues its Deed of Company Arrangement. | 27/07/2016 |
At the adjourned major meeting of creditors held on 17 June 2016, creditors resolved for the company to execute a DOCA and that deed administrators were appointed. On 8 July 2016, the company executed the DOCA and on 15 July 2016 the administrators executed the DOCA. | 19/07/2016 |
Richard Albarran, Brent Kijurina and Cameron Shaw are appointed Administrators of the Company | 29/02/2016 |
The following entity (Medivac Limited) has not paid their annual listing fees in respect of the year ending 30 June 2016 but the securities are already suspended from official quotation. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm AEST on Monday 31 August 2015 will be removed from the official list with effect from the close of trading on Monday 31 August 2015 | 25/08/2015 |
The company has a capital raising initiative that has received a commitment for a total amount of $200,000 loan from sophisticated investors. The proceeds are to be used predominately to finalise the outstanding Half-Year and Annual Report and on-going corporate overheads. | 07/08/2015 |
provides a general update on the Company | 30/07/2014 |
The Board of Medivac Limited (Medivac or the Company) is pleased to announce that it has agreed to acquire a commercial property at Tuggerah NSW as the first step in building a property fund to be managed by the Company. Funding for the transaction will be by first mortgage finance (65%) and the balance in shares of Medivac. The property is leased to a major international corporate | 07/03/2014 |
the Board has therefore resolved to establish two new business units to assist in shortening its realisation cycle from investments and balance the Company's overall performance. The two new subsidiaries will focus on: ï‚· Private to public investment; and ï‚· Special situation and secured lending. Both of these areas have shorter investment cycles and easier valuation metrics. The Company will make further announcements detailing these opportunities as funding and transactions are finalised | 30/01/2014 |
advises that further to its announcement of 1 October 2013, the Company's 2013 Annual Report is pending finalisation, subject to the following items being completed:  Formal confirmation that the La Jolla facility will be extended for a twelve month period; this has been agreed in-principle by the parties, subject to payment commitments being settled;  Finalisation of a partly paid convertible note facility from a group of directors and major shareholders to support the Company's working capital requirements. This facility will provide up to $500,000 over the next two years. Two of the notes have been applied for by directors and will require shareholder approval, to be sought at the upcoming AGM | 04/11/2013 |
suspended from Official Quotation from the commencement of trading today 1 October 2013 following failure to lodge their Full Year Accounts for the period ended 30 June 2013 in accordance with Listing rules | 02/10/2013 |
The suspension of trading in the securities of Medivac Limited (the "Company") will be lifted prior to the commencement of trading on Thursday, 29 August 2013 in accordance with listing rule 17.9, following the payment of the Company" annual listing fees. Security Code: MDV | 28/08/2013 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately. | 23/08/2013 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 02/11/2011 |
shares reinstated to quotation following lodgement of the company's financial reports to 31 December 2005 | 10/04/2006 |
shares suspended from quotation following failure to lodge with ASX, the company's financial reports to 31 December 2005 | 17/03/2006 |
name changed from Nautilus Australia Limited | 22/01/2004 |
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
the company, now GROWTH CAPITAL GROUP LIMITED, emerges from administration | 17/02/2021 |
company has been renamed GROWTH CAPITAL GROUP LIMITED and is still in external administration | 24/11/2020 |
the Deed Administrators are currently liaising with a Director of the company in relation to a potential variation of the Deed of Company Arrangement and convening of a shareholders meeting | 22/07/2019 |
delisted from the close of trading on Monday, 3 October 2016 pursuant to Listing rule 17.12. | 03/10/2016 |
we understand the company failed and was delisted following ASX's refusal of an extension to the 1 October 2016 relisting deadline | 03/10/2016 |
The Company has terminated the Term Sheet entered into with Brand TV Media Pty Ltd ("BTV") announced on 29 August 2016. The ASX has refused the Company an extension from the 1 October 2016 relisting deadline and as such the Company acknowledges that it is unable to satisfy the Indicative Timetable announced and relevant Conditions Precedent within the Term Sheet. The Company and BTV have executed a letter of settlement, terminating the Term Sheet which releases one another from all liabilities thereunder. The board of MDV is disappointed with this outcome. | 26/09/2016 |
Medivac Limited announces that the Company has on 26 August 2016 entered into a binding term sheet with the shareholders of Brand TV Media Pty Ltd in relation to the proposed acquisition of the entire equity interest in Brand TV Media Pty Ltd by the Company. The Proposed Acquisition will result in a Reverse Takeover of the Company as defined in Chapter 1 and 2 of the Listing Rules of ASX and is subject to, inter alia, the approval of the ASX and the approval of the shareholders of the Company at a general meeting of shareholders to be convened. | 29/08/2016 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation. | 23/08/2016 |
The company issues its Deed of Company Arrangement. | 27/07/2016 |
At the adjourned major meeting of creditors held on 17 June 2016, creditors resolved for the company to execute a DOCA and that deed administrators were appointed. On 8 July 2016, the company executed the DOCA and on 15 July 2016 the administrators executed the DOCA. | 19/07/2016 |
Richard Albarran, Brent Kijurina and Cameron Shaw are appointed Administrators of the Company | 29/02/2016 |
The following entity (Medivac Limited) has not paid their annual listing fees in respect of the year ending 30 June 2016 but the securities are already suspended from official quotation. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm AEST on Monday 31 August 2015 will be removed from the official list with effect from the close of trading on Monday 31 August 2015 | 25/08/2015 |
The company has a capital raising initiative that has received a commitment for a total amount of $200,000 loan from sophisticated investors. The proceeds are to be used predominately to finalise the outstanding Half-Year and Annual Report and on-going corporate overheads. | 07/08/2015 |
provides a general update on the Company | 30/07/2014 |
The Board of Medivac Limited (Medivac or the Company) is pleased to announce that it has agreed to acquire a commercial property at Tuggerah NSW as the first step in building a property fund to be managed by the Company. Funding for the transaction will be by first mortgage finance (65%) and the balance in shares of Medivac. The property is leased to a major international corporate | 07/03/2014 |
the Board has therefore resolved to establish two new business units to assist in shortening its realisation cycle from investments and balance the Company's overall performance. The two new subsidiaries will focus on: ï‚· Private to public investment; and ï‚· Special situation and secured lending. Both of these areas have shorter investment cycles and easier valuation metrics. The Company will make further announcements detailing these opportunities as funding and transactions are finalised | 30/01/2014 |
advises that further to its announcement of 1 October 2013, the Company's 2013 Annual Report is pending finalisation, subject to the following items being completed:  Formal confirmation that the La Jolla facility will be extended for a twelve month period; this has been agreed in-principle by the parties, subject to payment commitments being settled;  Finalisation of a partly paid convertible note facility from a group of directors and major shareholders to support the Company's working capital requirements. This facility will provide up to $500,000 over the next two years. Two of the notes have been applied for by directors and will require shareholder approval, to be sought at the upcoming AGM | 04/11/2013 |
suspended from Official Quotation from the commencement of trading today 1 October 2013 following failure to lodge their Full Year Accounts for the period ended 30 June 2013 in accordance with Listing rules | 02/10/2013 |
The suspension of trading in the securities of Medivac Limited (the "Company") will be lifted prior to the commencement of trading on Thursday, 29 August 2013 in accordance with listing rule 17.9, following the payment of the Company" annual listing fees. Security Code: MDV | 28/08/2013 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately. | 23/08/2013 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 02/11/2011 |
shares reinstated to quotation following lodgement of the company's financial reports to 31 December 2005 | 10/04/2006 |
shares suspended from quotation following failure to lodge with ASX, the company's financial reports to 31 December 2005 | 17/03/2006 |
name changed from Nautilus Australia Limited | 22/01/2004 |
Your browser may reflect a date of printing in American format.
Hi \n\nI am an MDV Shareholder and so is my SMSF. The shares are worthless I guess now but how do I transfer my SMSF shares to myself just in case MDV rises from the Ashes? | 15/12/2017 13:04:46 |
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 12/03/2012 | Helen Owens | On market | 186,020 | $0.013 | $2,418 |
| 28/02/2012 | Paul McPherson | On market | 1,300,000 | $0.010 | $13,020 |
| 20/12/2011 | Paul McPherson | On market | 450,000 | $0.016 | $7,363 |
| 31/08/2011 | Paul McPherson | On market | 5,000,000 | $0.003 | $15,000 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Luke Connor | Director | 15/07/2016 |
| Dean Scook | Director | 15/07/2016 |
| Carol Hardie | Director | 15/07/2016 |
| Michael Higginson | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Phillip Pryor | Chairman | 07/08/2015 | 15/07/2016 |
| Rodger Johnston | Managing Director | 02/07/2012 | 15/07/2016 |
| Craig Hitchins | Executive Director | 30/04/2013 | 15/07/2016 |
| Robert Crossman | Non Exec Chairman | 29/07/2014 | 07/01/2015 |
| Peter Elliott | Non Exec Director | 06/03/2014 | 30/07/2014 |
| Kieran Honour | Executive Chairman | 27/11/2012 | 29/07/2014 |
| John Evans | Independent Director | 01/12/2007 | 30/04/2013 |
| Paul McPherson | Non Exec Director | 14/08/2006 | 17/12/2012 |
| Reba Meagher | Non Exec Director | 01/02/2011 | 27/11/2012 |
| Helen Owens | Non Exec Director | 01/02/2011 | 27/11/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
